Showing 1 - 20 results of 28 for search 'David M G Halpin', query time: 0.06s
Refine Results
-
1
Tiotropium in asthma: what is the evidence and how does it fit in? by David M.G. Halpin
Published 2016-01-01
Article -
2
Precision medicine in chronic obstructive pulmonary disease by David M.G. Halpin, Peifang Wei
Published 2022-05-01
Article -
3
-
4
Inhalation Devices by Petra Moroni-Zentgraf, Omar S. Usmani, David M. G. Halpin
Published 2018-01-01
Article -
5
-
6
-
7
Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial by Donald P. Tashkin, Marc Miravitlles, Bartolomé R. Celli, Norbert Metzdorf, Achim Mueller, David M. G. Halpin, Antonio Anzueto
Published 2018-10-01
Article -
8
Clinical effectiveness of once-daily fluticasone furoate/umeclidinium/vilanterol in usual practice: the COPD INTREPID study design by Sally Worsley, Neil Snowise, David M.G. Halpin, Dawn Midwinter, Afisi S. Ismaila, Elaine Irving, Leah Sansbury, Maggie Tabberer, David Leather, Chris Compton
Published 2019-11-01
Article -
9
Assessing the comparative effects of interventions in COPD: a tutorial on network meta-analysis for clinicians by Katrin Haeussler, Afisi S. Ismaila, Mia Malmenäs, Stephen G. Noorduyn, Nathan Green, Chris Compton, Lehana Thabane, Claus F. Vogelmeier, David M. G. Halpin
Published 2024-12-01
Article -
10
-
11
-
12
-
13
Comparative Responses in Lung Function Measurements with Tiotropium in Adolescents and Adults, and Across Asthma Severities: A Post Hoc Analysis by David M. G. Halpin, Eckard H. Hamelmann, Peter A. Frith, Petra M. Moroni-Zentgraf, Benjamin van Hecke, Anna Unseld, Huib A. M. Kerstjens, Stanley J. Szefler
Published 2020-03-01
Article -
14
Association of elevated fractional exhaled nitric oxide concentration and blood eosinophil count with severe asthma exacerbations by David B. Price, Sinthia Bosnic-Anticevich, Ian D. Pavord, Nicolas Roche, David M. G. Halpin, Leif Bjermer, Omar S. Usmani, Guy Brusselle, Simon Wan Yau Ming, Sarang Rastogi
Published 2019-08-01
Article -
15
Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospe... by Afisi S. Ismaila, Kieran J. Rothnie, Robert P. Wood, Victoria L. Banks, Lucinda J. Camidge, Alexandrosz Czira, Chris Compton, Raj Sharma, Shannon N. Millard, Olivia Massey, David M. G. Halpin
Published 2023-09-01
Article -
16
Correction: Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation... by Afisi S. Ismaila, Kieran J. Rothnie, Robert P. Wood, Victoria L. Banks, Lucinda J. Camidge, Alexandrosz Czira, Chris Compton, Raj Sharma, Shannon N. Millard, Olivia Massey, David M. G. Halpin
Published 2024-04-01
Article -
17
Blood eosinophil count predicts treatment failure and hospital readmission for COPD by Marjan Kerkhof, Isha Chaudhry, Ian D. Pavord, Marc Miravitlles, Chin Kook Rhee, David M.G. Halpin, Omar S. Usmani, Rupert Jones, Janwillem Kocks, Marianna Alacqua, Tamsin Morris, Alan Kaplan, David B. Price
Published 2020-11-01
Article -
18
INTREPID: single- versus multiple-inhaler triple therapy for COPD in usual clinical practice by David M.G. Halpin, Sally Worsley, Afisi S. Ismaila, Kai-Michael Beeh, Dawn Midwinter, Janwillem W.H. Kocks, Elaine Irving, Jose M. Marin, Neil Martin, Maggie Tabberer, Neil G. Snowise, Chris Compton
Published 2021-06-01
Article -
19
Outcomes of patients with COPD switching from multiple-inhaler to once-daily single-inhaler triple therapy in a real-world primary care setting in England: a retrospective pre-post... by Raj Sharma, Claus F Vogelmeier, Kieran J Rothnie, David M G Halpin, Alexandrosz Czira, Chris Compton, Afisi S Ismaila, Robert P Wood, Victoria L Banks, Lucinda J Camidge, Olivia K I Massey, Monica Seif
Published 2024-03-01
Article -
20
Time‐Dependent Risk of Cardiovascular Events Following an Exacerbation in Patients With Chronic Obstructive Pulmonary Disease: Post Hoc Analysis From the IMPACT Trial by Mark T. Dransfield, Gerard J. Criner, David M. G. Halpin, MeiLan K. Han, Benjamin Hartley, Ravi Kalhan, Peter Lange, David A. Lipson, Fernando J. Martinez, Dawn Midwinter, Dave Singh, Robert Wise, Ken M. Kunisaki
Published 2022-09-01
Article